Iris Nederlof

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

Leonie Voorwerk, Maarten Slagter, Hugo M. Horlings et al. · Nature Medicine · 2019 · 889 citations · Full text

Medicine, Immunology, Oncology +17

Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer

Dora Hammerl, John W.M. Martens, Mieke Timmermans et al. · Nature Communications · 2021 · 251 citations · Full text

Medicine, Immunology, Oncology +17

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

Zuzana Kos, Elvire Roblin, Rim S. Kim et al. · npj Breast Cancer · 2020 · 206 citations · Full text

Medicine, Oncology, Pathology +16

DeepSMILE: Contrastive self-supervised pre-training benefits MSI and HRD classification directly from H&E whole-slide images in colorectal and breast cancer

Yoni Schirris, Efstratios Gavves, Iris Nederlof et al. · Medical Image Analysis · 2022 · 133 citations · Full text

Computing, Computer Science, Oncology +15

Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial

Iris Nederlof, Olga I. Isaeva, Manon de Graaf et al. · Nature Medicine · 2024 · 67 citations · Full text

Life Sciences, Immunology, Oncology +17